Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001193125-26-285558

Chief Commercial Officer sold 2,867 shares at $45.03 ($129,101)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Wiley Matthew T. · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-25 Sale : show line 1 in the form 10b5-1 −2,867 $45.03 $129,101 174,633 D
Open-market sales · 2,867 sh · avg $45.03 · $129,101
Loading xslF345X06/ownership.xml…